Jaguar Health Inc (NASDAQ:JAGX)’s traded shares stood at 1.33 million during the last session, with the company’s beta value hitting 1.07. At the close of trading, the stock’s price was $0.25, to imply an increase of 3.67% or $0.0 in intraday trading. The JAGX share’s 52-week high remains $21.60, putting it -8540.0% down since that peak but still an impressive 12.0% since price per share fell to its 52-week low of $0.22. The company has a valuation of $4.17M, with an average of 0.72 million shares in intraday trading volume over the past 10 days and average of 458.17K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Jaguar Health Inc (JAGX), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give JAGX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.74.
Jaguar Health Inc (NASDAQ:JAGX) trade information
After registering a 3.67% upside in the last session, Jaguar Health Inc (JAGX) has traded red over the past five days. The 5-day price performance for the stock is -47.08%, and -74.59% over 30 days. With these gigs, the year-to-date price performance is -74.85%. Short interest in Jaguar Health Inc (NASDAQ:JAGX) saw shorts transact 0.95 million shares and set a 2.57 days time to cover.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 86.10% for the past 5-year period. While 2025 is set for a 99.26% return in earnings, projections for the next 5 years are at 79.17% annually.
JAGX Dividends
Jaguar Health Inc has its next earnings report out on 2024-Nov-12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Jaguar Health Inc (NASDAQ:JAGX)’s Major holders
Jaguar Health Inc insiders hold 14.81% of total outstanding shares, with institutional holders owning 1.71% of the shares at 2.01% float percentage. In total, 1.71% institutions holds shares in the company.
We also have Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Jaguar Health Inc (JAGX) shares. Going by data provided on Dec 31, 2024, Vanguard Extended Market Index Fund holds roughly 59.5 shares. This is just over 0.36% of the total shares, with a market valuation of $15113.0. Data from the same date shows that the other fund manager holds a little less at 50.91, or 0.31% of the shares, all valued at about 12929.0.
